These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37586466)

  • 1. Gastrodin destabilizes survivin and overcomes pemetrexed resistance.
    Liao J; Qing X; Deng G; Xiao Y; Fu Y; Han S; Li X; Gan Y; Li W
    Cell Signal; 2023 Oct; 110():110851. PubMed ID: 37586466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivin degradation by bergenin overcomes pemetrexed resistance.
    Li X; Liang Q; Zhou L; Deng G; Xiao Y; Gan Y; Han S; Liao J; Wang R; Qing X; Li W
    Cell Oncol (Dordr); 2023 Dec; 46(6):1837-1853. PubMed ID: 37542022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells.
    Hwang KE; Kim YS; Jung JW; Kwon SJ; Park DS; Cha BK; Oh SH; Yoon KH; Jeong ET; Kim HR
    Oncotarget; 2015 Oct; 6(30):29482-96. PubMed ID: 26334320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLAUR Confers Resistance to Gefitinib Through EGFR/P-AKT/Survivin Signaling Pathway.
    Zhou J; Kwak KJ; Wu Z; Yang D; Li J; Chang M; Song Y; Zeng H; Lee LJ; Hu J; Bai C
    Cell Physiol Biochem; 2018; 47(5):1909-1924. PubMed ID: 29961070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promotion of ubiquitination-dependent survivin destruction contributes to xanthohumol-mediated tumor suppression and overcomes radioresistance in human oral squamous cell carcinoma.
    Li M; Gao F; Yu X; Zhao Q; Zhou L; Liu W; Li W
    J Exp Clin Cancer Res; 2020 May; 39(1):88. PubMed ID: 32410646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo.
    Zhang K; Li Y; Liu W; Gao X; Zhang K
    Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YM155 sensitizes non-small cell lung cancer cells to EGFR-tyrosine kinase inhibitors through the mechanism of autophagy induction.
    Dai CH; Shu Y; Chen P; Wu JN; Zhu LH; Yuan RX; Long WG; Zhu YM; Li J
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3786-3798. PubMed ID: 30315932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of simvastatin on the resistance to EGFR tyrosine kinase inhibitors in a non-small cell lung cancer with the T790M mutation of EGFR.
    Hwang KE; Kwon SJ; Kim YS; Park DS; Kim BR; Yoon KH; Jeong ET; Kim HR
    Exp Cell Res; 2014 May; 323(2):288-96. PubMed ID: 24631288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC; Bathina M; Fiscus RR
    J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA.
    Nie P; Hu W; Zhang T; Yang Y; Hou B; Zou Z
    Cell Physiol Biochem; 2015; 35(6):2255-71. PubMed ID: 25895606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pemetrexed Disodium Heptahydrate Induces Apoptosis and Cell-cycle Arrest in Non-small-cell Lung Cancer Carrying an EGFR Exon 19 Deletion.
    Mohiuddin M; Kasahara K
    Anticancer Res; 2021 Jun; 41(6):2963-2977. PubMed ID: 34083287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shikonin Inhibits Non-Small-Cell Lung Cancer H1299 Cell Growth through Survivin Signaling Pathway.
    Wang H; Zuo J
    Anal Cell Pathol (Amst); 2021; 2021():6435393. PubMed ID: 34782853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement.
    Kwon JH; Kim KJ; Sung JH; Suh KJ; Lee JY; Kim JW; Kim SH; Lee JO; Kim JW; Kim YJ; Lee KW; Kim JH; Bang SM; Kim S; Yoon SS; Lee JS
    Cells; 2019 Nov; 8(12):. PubMed ID: 31795298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer.
    Yu X; Zhang Y; Cavazos D; Ma X; Zhao Z; Du L; Pertsemlidis A
    Cell Death Dis; 2018 Feb; 9(2):193. PubMed ID: 29416000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butein promotes ubiquitination-mediated survivin degradation inhibits tumor growth and overcomes chemoresistance.
    Dong X; Liu W; Li X; Gan Y; Zhou L; Li W; Xie L
    Sci Rep; 2022 Nov; 12(1):20644. PubMed ID: 36450751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrine induces mitochondrial apoptosis in cisplatin-resistant non-small cell lung cancer cells via suppression of β-catenin/survivin signaling.
    Wang HQ; Jin JJ; Wang J
    Oncol Rep; 2015 May; 33(5):2561-6. PubMed ID: 25760455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroartemisinin suppresses STAT3 signaling and Mcl-1 and Survivin expression to potentiate ABT-263-induced apoptosis in Non-small Cell Lung Cancer cells harboring EGFR or RAS mutation.
    Yan X; Li P; Zhan Y; Qi M; Liu J; An Z; Yang W; Xiao H; Wu H; Qi Y; Shao H
    Biochem Pharmacol; 2018 Apr; 150():72-85. PubMed ID: 29360439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase.
    Ding X; Gu Y; Jin M; Guo X; Xue S; Tan C; Huang J; Yang W; Xue M; Zhou Q; Wang W; Zhang Y
    Theranostics; 2020; 10(13):6048-6060. PubMed ID: 32483437
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardamonin inhibits the proliferation and metastasis of non-small-cell lung cancer cells by suppressing the PI3K/Akt/mTOR pathway.
    Zhou X; Zhou R; Li Q; Jie X; Hong J; Zong Y; Dong X; Zhang S; Li Z; Wu G
    Anticancer Drugs; 2019 Mar; 30(3):241-250. PubMed ID: 30640793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periostin Contributes to Cisplatin Resistance in Human Non-Small Cell Lung Cancer A549 Cells via Activation of Stat3 and Akt and Upregulation of Survivin.
    Hu W; Jin P; Liu W
    Cell Physiol Biochem; 2016; 38(3):1199-208. PubMed ID: 26982182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.